Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Tissue Engineering, Biofabrication & 3D-Bioprinting in Life Sciences

Stuart Williams's Biography



Stuart Williams, Director, University of Louisville

Dr. Stuart Williams received his Ph.D. in Cell Biology from the University of Delaware followed by postdoctoral training in Pathology at the Yale School of Medicine.
During the period 1980 to 1990 he held a faculty appointment at Jefferson Medical College where he was Director of Research in the Department of Surgery.
In 1990 Dr. Williams joined the faculty at the University of Arizona and established the Section of Surgical Research in the Department of Surgery.
In 1997 he founded the University of Arizona Biomedical Engineering Program creating a research and educational link between the Medical School and College of Engineering. He held faculty positions jointly in Biomedical Engineering, Surgery, Physiology and Materials Science and Engineering. In 2007 Dr. Williams was selected as the Scientific Director of the newly established Cardiovascular Innovation Institute, a partnership between Jewish Hospital and the University of Louisville in Louisville Kentucky. Dr. Williams’ research interests have focused on medical devices, regenerative medicine and infection control. He developed and patented the first methods to use fat-derived stem cells for therapeutic use. He developed the Bioficial Organs Program in Louisville with a focus on 3D printing of orgrans.
Dr. Williams has authored over 300 scientific publications.
His entrepreneurial spirit has resulted in 18 issued US patents with numerous patents pending. He has founded four biotechnology companies, maintained active managerial positions and has been an active consultant to the medical device and pharmaceutical community.
He is a Fellow of the American Heart Association and a Fellow of the American Institute of Medical and Biological Engineering.

Stuart Williams Image

Building Blood Vessels Using Tissue Engineering and 3D-Bioprinting

Friday, 18 March 2016 at 12:30

Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com

The cardiovascular system is comprised of blood vessels with varying dimensions and functions.   Successful creation of tissue constructs and organs will require the establishment of a functional vascular system that responds to the metabolic needs of the implant.  We continue to develop operating room compatible systems for the isolation of autologous cells for use in reconstituting blood vessels of various calibers.  We have utilized 3D-Bioprinting to create pre-vascularized tissue constructs with a goal of assembling complete organs for implantation.


Add to Calendar ▼2016-03-17 00:00:002016-03-18 00:00:00Europe/LondonTissue Engineering, Biofabrication and 3D-Bioprinting in Life SciencesTissue Engineering, Biofabrication and 3D-Bioprinting in Life Sciences in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com